Status:
COMPLETED
Post Vaccination Adverse Events in Covid-19 Vaccine Recipients
Lead Sponsor:
Islamia University of Bahawalpur
Collaborating Sponsors:
District Health Authority (DHA) Bahawalpur District Bahawalpur, Government of Punjab.
Conditions:
COVID-19 Vaccination
Vaccine Adverse Reaction
Eligibility:
All Genders
12+ years
Brief Summary
Covid-19 pandemic is caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-Cov-2) since its outbreak 2019. Protection against Covid-19 can be achieved through global immunization. Various v...
Detailed Description
Bahawalpur District of Punjab province has population of 3.998 million and among these 2.6 million above 12 years of age are eligible for vaccination against SARS-Cov-2. 28 centers were established fo...
Eligibility Criteria
Inclusion
- Age \>12 year Vaccinated (Single Dose, Double Dose, Booster Dose) Clinical diagnosis of Allergic reactions and hypersentivity, Cardiovascular diseases Musculoskeletal diseases Respiratory disease Immunological disease Kidney diseases
Exclusion
- Age \<12 years of age Not vaccinated History of disease before vaccination
- \-
Key Trial Info
Start Date :
February 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
3515 Patients enrolled
Trial Details
Trial ID
NCT05254977
Start Date
February 26 2022
End Date
March 30 2022
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College of Conventional Medicine
Bahawalpur, Punajb, Pakistan, 63100